Association of the Mr 58,000 postsynaptic protein of electric tissue with Torpedo dystrophin and the Mr 87,000 postsynaptic protein by unknown
THE JOURNAL OF BIOLOGICAL CHEMISTRY 
0 1992 by The American Society for Biochemistry and Molecular Biology, Inc. 
Vol. 267, No. 9, Issue of March 25, pp. 6213-6218,1992 
Printed in U. S. A .  
Association of the Mr 58,000 Postsynaptic  Protein of Electric Tissue 
with Torpedo Dystrophin  and the M;. 87,000 Postsynaptic  Protein* 
(Received for publication, October 21, 1991) 
Margaret H. Butler$$, Karen DouvilleS, Amy A. MurnaneSll, Neal R. Kramarcy 11, 
Jonathan B.  Cohen**, Robert Sealock11 , and Stanley C. Froehnerz $$ 
From the $Department of Bwchemistly,  Dartmouth Medical School, Hanouer, New  Hampshire 03755, the )I Department of 
Physiology,  University of North Carolina,  Chapel  Hill, North Carolina 27599, and  the  **Department of Anatomy and 
Neurobiology,  Washington  University,  St. Louis, Missouri 631 10 
Dystrophin was purified by immunoaffinity chro- 
matography  from detergent-solubilized Torpedo elec- 
tric organ postsynaptic membranes using monoclonal 
antibodies. A major doublet of proteins at M, 58,000 
and minor proteins at M, 87,000, M, 45,000, and M, 
30,000 reproducibly copurified with  dystrophin.  The 
M, 68,000 and M, 87,000 proteins  were  identical  to 
previously described peripheral membrane proteins 
(M, 58,000 protein  and 87,000 protein) whose muscle 
homologs are associated with  the sarcolemma (Froeh- 
ner, S. C., Murnane, A. A,, Tobler, M., Peng, H. B., 
and Sealock, R. (1987) J. Cell Biol. 104, 1633-1646; 
Carr, C., Fischbach, G .  D., and Cohen, J. B. (1989) J. 
Cell Biol. 109, 1753-1764). The  copurification of dys- 
trophin  and M, 58,000 protein  was shown to be spe- 
cific, since dystrophin  was also captured  with  a mono- 
clonal  antibody  against the M, 58,000 protein  but not 
by  several  control antibodies. The M, 87,000 protein 
was a major component (along with the M, 58,000 
protein) in material  purified on anti-58,000 columns, 
suggesting that  the M, 58,000 protein  forms a distinct 
complex with  the M, 87,000 protein, as well as with 
dystrophin. Immunofluorescence staining of skeletal 
and  cardiac muscle from the dystrophin-minus mdx 
moube with  the  anti-58,000  antibody  was confined to 
the sarcolemma as in normal muscle but was much 
reduced in intensity,  even though immunoblotting 
demonstrated that  the contents of Mr 58,000 protein 
in normal and mdx muscle were comparable. Thus, the 
M, 58,000 protein appears to associate inefficiently 
with  the sarcolemmal membrane in  the absence of dys- 
trophin.  This deficiency may contribute  to  the mem- 
brane abnormalities that lead to muscle necrosis in 
dystrophic muscle. 
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Duchenne muscular dystrophy (DMD)’ is a fatal genetic 
disease characterized by skeletal muscle necrosis and wasting 
(Engel, 1986). The protein product encoded by the DMD  gene 
is a 427-kDa protein called dystrophin which has major ho- 
mologies to b-spectrin and a-actinin (Hoffman et d., 1987; 
Koenig et al., 1988). Dystrophin occurs as  part of a complex 
of proteins (Ervasti et al., 1991) associated with the cyto- 
plasmic surface of the plasma membrane in normal skeletal, 
cardiac, and  smooth muscle (Bonilla et al., 1988). It is absent 
or severely reduced in amount in muscle from Duchenne 
patients  and  the rndx mouse (Bonilla et al., 1988; Hoffman et 
al., 1987; Hoffman and Kunkel, 1989), a dystrophin-minus 
animal model for DMD (Bullfield et al., 1984). The function 
of dystrophin  is unknown for certain, although it is  believed 
to provide mechanical stability to  the membrane by analogy 
to erythrocyte  spectrin  (Mandel 1989) and/or to regulate the 
activities of calcium leak channels (Fong et aL, 1990) or 
calcium permeable mechano-transducing channels (Franco 
and  Lansman, 1990). Evaluation of these hypotheses would 
be greatly aided by identification of the activities of proteins 
with which dystrophin is associated. In addition, efficient 
gene replacement therapy for DMD may require shortened 
forms of the dystrophin gene (Acsadi et al., 1991). Construc- 
tion of optimal short forms will require knowledge of dystro- 
phin binding proteins  and  their binding sites on dystrophin. 
We have approached the question of dystrophin-associated 
muscle proteins  through the use of acetylcholine receptor-rich 
postsynaptic membranes isolated from electric tissue of elec- 
tric rays (Torpedo sp.). The electrogenic cells, or electro- 
plaques, which make up the tissue are derived embryologically 
from immature striated muscle cells (Fox and Richardson, 
1979) and  retain many morphological and biochemical simi- 
larities to mammalian skeletal muscle. In particular, they 
contain  a very large protein which  is  homologous to human 
muscle dystrophin by immunological criteria (Chang et al., 
1989; Jasmin et al., 1990; Sealock et al., 1991) and deduced 
partial  amino acid sequence (Yeadon et al., 1991). This Tor- 
pedo dystrophin  appears to be confined to  the innervated face 
of the electroplaque (Jasmin et al., 1990; Sealock et al., 1991) 
along with several other cytoplasmic, peripheral membrane 
proteins that also have homologs in muscle (reviewed in 
Froehner, 1991). These include a  protein of M, 43,000 which 
is directly involved in AChR clustering (Froehner et al., 1990), 
and proteins of M ,  58,000, 87,000, and 270,000 or 300,000 
(Froehner et al., 1987; Carr et al., 1989;  Woodruff et al., 1987). 
The M, 270,000/300,000 protein  has been shown to be iden- 
’ The abbreviations used are: DMD, Duchenne muscular dystro- 
phy; AChR, nicotinic acetylcholine receptor; EGTA, [ethylene- 
bis(oxyethylenenitri1o)ltetraacetic acid FITC, fluorescein isothiocy- 
anate; mAb, monoclonal antibody; SDS, sodium dodecyl sulfate. 
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tical to Torpedo dystrophin,  with the discrepancy in reported 
molecular  weights  of the muscle  and Torpedo proteins result- 
ing from difficulties in gel  calibration  for  very  large proteins 
(Sealock et al., 1991). In previous  work,  we  showed that the 
detailed distributions  of  dystrophin  and the muscle  homolog 
of the M ,  58,000 protein are  very similar in cultured Xenopus 
muscle (Kramarcy and Sealock, 1990), as in adult muscle 
(Carr et al., 1989;  Froehner et al., 1987), and  raised the 
possibility that dystrophin  and the M,  58,000 protein may  be 
associated. In this study, we demonstrate their association in 
detergent extracts of AChR-rich membranes from Torpedo 
and show that the association of the M,  58,000 protein2 with 
muscle sarcolemma is altered in dystrophin-minus muscle. 
We  also  provide  evidence  for a distinct complex containing 
the M ,  58,000 and 87,000 proteins. 
MATERIALS AND  METHODS 
Antibodies and Other Materials-The mAbs used in this work have 
been described in previous publications as follows: anti-dystrophin 
mAb 1351 (Froehner et al., 1987), anti-43,000 mAb 1234 (Peng  and 
Froehner 1985), anti-AChR mAb 88B (Froehner et al., 1983), anti- 
87,000 mAb 20H2 (Carr et al., 1989), anti-spectrin mAb 4F8 (Bloch 
and Morrow, 1989), and rabbit  anti-vinculin (Bloch and Hall, 1983). 
Torpedo nobiliana electric organ, frozen in liquid nitrogen, was ob- 
tained from Biofish, Inc. (Georgetown, MA). 
Immunoaffinity Purification of the Dystrophin Complex-Torpedo 
acetylcholine receptor-enriched membranes were purified according 
to Porter and Froehner (1983) or with additional  proteinase  inhibitors 
in all solutions (5 pg/ml each of leupeptin, aprotinin,  and  antipain, 
and 0.5 pg/ml of pepstatin; Chapel Hill laboratory).  Membranes (2 
mg/ml) were solubilized in buffer A (150 mM NaCl, 5 mM EDTA, 5 
mM EGTA, 5 pg/ml leupeptin, 2.5 pg/ml phenylmethylsulfonyl fluo- 
ride, 5 pg/ml pepstatin,  5 mM iodoacetamide, 10 mM sodium phos- 
phate, pH 7.4 or 400 mM NaCI, 5 mM EDTA,  10 mM sodium 
phosphate, pH 7.4, plus the proteinase inhibitor mix listed above) 
containing 1%  Triton X-100, incubatedon ice for 20 min, and clarified 
by centrifugation. MAb  IgG-Affigel columns were prepared as previ- 
ously described (LaRochelle and Froehner, 1987). MAb IgG-Sepha- 
rose columns were prepared according to recommendations of Phar- 
macia LKB Biotechnology Inc. The  extracts were incubated  in  batch 
with immunoaffinity resins (1-2 ml) for 1-2  h. The resins were 
transferred to columns and washed extensively with buffer A  contain- 
ing 1% Triton or buffer A/Triton followed  by buffer A alone. Columns 
were eluted with elution buffer (0.1 M NHIAc or with 0.1 M triethyl- 
amine plus the proteinase inhibitor mix) at pH 11.5. Neutralized 
fractions were precipitated with trichloroacetic acid prior to gel 
electrophoresis. The different solution compositions used gave very 
similar results, but  the yields of dystrophin complex appears to be 
consistently higher in the Chapel Hill laboratory (second set of 
conditions in each pair above). 
In the experiment shown (see Fig. 2), the  extract was incubated 
sequentially with anti-43,000 mAb 1234 IgG-Affigel 10, anti-AChR 
mAb 88B IgG-Affigel 10, and  then anti-dystrophin mAb 1808 IgG- 
Affigel 10, and the columns were washed and eluted as described 
above. 
SDS-Gel Electrophoresis and Zmmunoblotting-Gel electrophoresis 
in a mini-gel system was performed as previously described (La- 
Rochelle and Froehner, 1987). For immunoblotting of dystrophin, 
proteins were transferred to nitrocellulose using the Tris glycine 
system (Sealock et al., 1991) in most cases. For all other proteins, 
transfer was carried out in 25 mM sodium phosphate, pH 6.5, a t  250 
mA for 2 h. 
For analysis of M,  58,000 protein  in  normal and mdx mouse skeletal 
and cardiac muscle, lower  leg muscles and  the  heart were dissected, 
frozen in liquid nitrogen, and pulverized with a cold mortar and 
We refer to all mAb 1351-reactive proteins in this paper as M, 
58,000 proteins. The proteins  in mouse skeletal and cardiac muscle 
typically migrated slightly more slowly on SDS gels than  the Torpedo 
protein (see Fig. 6),  and  apparent molecular weights of 51,000 (Tor- 
pedo electric organ) and 48,000 (Xenopus skeletal muscle) have also 
been reported (Carr et al., 1989; Chen et al., 1990). Since the reasons 
for these different values are unknown, a single name for these 
proteins is used for simplicity. 
pestle. Samples were then dissolved in 1% SDS, 1 mM phenylmeth- 
ylsulfonyl fluoride, 1 mM benzamidine, 5 mM EGTA, 2 units/ml 
trasolyl, a t  a  concentration of  250  mg  of tissue/ml, boiled for 4 min, 
and centrifuged 2 min in a microcentrifuge to remove insoluble 
material. The protein concentration of the  supernatant was deter- 
mined by the Lowry method. Aliquots (75-150 pg) were subjected to 
gel electrophoresis and  then transferred to nitrocellulose in 25 mM 
sodium phosphate, pH 6.5. 
MAbs were typically used at  concentrations of  25  nM  IgG. Second 
antibody was goat anti-mouse IgG conjugated to alkaline  phosphatase 
(Jackson  Immunoresearch; 1:500) or "'1-rabbit anti-mouse IgG 
(Froehner et al., 1983). 
Immunofluorescence Microscopy-Frozen sections (6 pm) of dia- 
phragm or gastrocnemius muscle were incubated sequentially with 
mAb I g G  (25-50 nM), biotinylated goat anti-mouse IgG, and FITC- 
avidin, according to established procedures. For analysis of cardiac 
muscle, 6-pm sections were incubated sequentially with FITC-deriv- 
atized anti-58,000 mAb 1351, rabbit anti-FITC  (East Acres; 1:150), 
and FITC-goat anti-rabbit IgG (Jackson Immunoresearch; 1:250). 
Substitution of primary antibodies with nonspecific mouse IgG or 
with monoclonals of the IgG, subclass directed against other antigens 
were used as control for nonspecific labeling. 
RESULTS 
Identification of dystrophin-associated proteins in AChR- 
rich membranes was accomplished by Triton X-100 solubi- 
lization of the membranes  followed  by  immunoaffinity  puri- 
fications using monoclonal antibodies. After  incubation  with 
the Triton extracts, antibody columns were washed exten- 
sively, and proteins were eluted at pH 11.5. In the experiment 
shown  in  Fig. 1, dystrophin  was  purified  from  one  portion of 
an extract using the anti-dystrophin mAb 1808,  and the M ,  
58,000 protein was  purified  from a second portion using the 
anti-58,000 mAb 1351. When subjected to SDS-polyacryl- 
amide gel electrophoresis, the eluate of the anti-dystrophin 
column contained a major protein corresponding to dystro- 
phin, a doublet  of proteins having mobility very similar to the 
M ,  58,000 protein (Froehner et al., 1987), and  weaker  bands 




FIG. 1. Immunoaffinity purifications  of dystrophin and M, 
58,000 protein. Dystrophin and  the M, 58,000 protein were purified 
from separate  portions of a Triton X-100 extract of Torpedo postsyn- 
aptic membranes using Sepharose-coupled mAb 1808 and 1351, re- 
spectively (see "Materials and Methods"). The products were ana- 
lyzea by SDS-gel electrophoresis and Coomassie Blue staining. Lane 
I ,  molecular weight standards (arrowheads) indicate M. 205,000, 
116,000, 97,400, 66,000, 45,000, and 29,000. Lane 2, proteins  eluted 
from the anti-dystrophin column. In addition to dystrophin (Dl, a 
prominent  doublet a t  approximately M, 58,000 and a weaker doublet 
a t  M, 87,000 were present. Additional weak bands at  M, 160,000, 
45,000, and 30,000 were also reproducibly present. The doublet near 
M, 200,000 presumably represents degradation products of dystrophin 
(Sealock et al., 1991). Lane 3, proteins eluted from the anti-58,000 
column include dystrophin and large amounts of the M, 87,000 protein 
as well as  the M, 58,000 protein and  the minor  proteins (M, 45,000 
and 30,000) present in the purified dystrophin. 
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a t  mobilities corresponding to M,  140,000,87,000,45,000, and 
30,000  (Fig. 1, lane 2). The two bands near M,  200,000  were 
presumably degradation products of dystrophin, since similar 
bands reacted with anti-dystrophin antibodies on immuno- 
blots in previous experiments (Sealock et al., 1991). The 
material purified on an anti-58,000 column from the second 
portion of the  extract contained proteins of M, 58,000 and M ,  
87,000 (both of which ran as doublets) and presumptive 
dystrophin (Fig. 1, lane 3 ) .  None of these  proteins was de- 
tectable in eluates from control mouse IgG columns incubated 
with detergent-solubilized membranes and  then washed and 
eluted as described  above (data not shown). 
Immunoblotting and additional purifications on columns 
containing antibodies against other Torpedo postsynaptic pro- 
teins were used to identify eluted proteins and to test  the 
specificity of our methods. In  a series of control experiments, 
a  Triton X-100 extract of postsynaptic membranes was passed 
sequentially through three monoclonal antibody columns de- 
rivatized with an anti-AChR, an anti-43,000, and an anti- 
dystrophin mAb, respectively. Each monoclonal used (see 
“Materials and Methods”) was of the IgGl subclass. After 
extensive wash, the columns were eluted at  pH 11.5, and  the 
eluates were subjected to SDS-polyacrylamide gel electropho- 
resis and immunoblotting. Dystrophin and the M,  58,000 
protein were specifically  recognized by  mAbs 1808 and 1351, 
respectively, on blots of the eluate from the third, anti- 
dystrophin column  (Fig. 2A, lanes 2 and 5) .  The M ,  58,000 
protein copurified with dystrophin even  when the column was 
washed thoroughly with 1 M NaCl prior to elution at  pH 11.5 
(data not shown). In  contrast, no AChR  (Fig. 2A, lane 4 )  and 
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FIG. 2. Specificity  of copurification of dystrophin and M. 
68,000 protein. Torpedo postsynaptic  membranes were solubilized 
in  Triton X-100 and  the detergent extract was passed sequentially 
through three antibody columns derivatized with mAbs to AChR 
(mAb 88B), the M, 43,000 protein (mAb 1234) and dystrophin (mAb 
1808), respectively. The columns were washed, eluted a t  pH 11.5, and 
the eluted proteins were analyzed by SDS-gel electrophoresis (lanes 
I ) and immunoblotting (A, lanes 2-6 or B and C, lanes 2-4). A, lane 
M, Torpedo membranes; lane 1, proteins  eluted from the  antidystro- 
phin column: dystrophin, and proteins of M, 87,000, 58,000, 45,000, 
and 30,000 (arrows, top to bottom). The same sample was immuno- 
blotted with mAbs to the M, 58,000 protein (lane 2 ), M, 43,000 
protein (lane 3 ) ,  AChR y and d subunits (lane 4), dystrophin (lane 
5 ) .  and control mouse IgG (lane 6). B, lane 1, proteins eluted from 
the anti-AChR column: a, 13, y, d subunits (arrows, bottom to top); 
lanes 2-4, immunoblotting with same  antibodies as in A. C, lane 1, 
proteins eluted from anti-43,000 column. Arrow indicates the M, 
43,000 protein; lanes 2-4, immunoblotting with the same  antibodies 
as in A .  
only very small amounts of the M,  43,000 protein (lane 3 )  
were detected in this fraction. The latter may not be signifi- 
cant, since similar amounts of the M,  43,000 protein were 
detected on immunoblots of the eluate from the anti-AChR 
column (Fig. 2B, lane 3) ,  and  the M,  43,000 protein and AChR 
are known not to be associated in detergent extracts. In 
contrast, the M,  58,000 protein was not visible in the eluates 
from the anti-AChR or anti-43,000 columns (Fig. 2, B and C, 
respectively), either by Coomassie Blue staining (lane 1 in 
each panel) or by immunoblotting (lane 2). Both of these 
columns gave efficient purification of their respective anti- 
gens,  however  (Figs. 2B, lane 4 and 2C, lane 3 ) .  These results 
establish that one or both of the  proteins in the copurifying 
doublet at  M, 58,000  was identical to  the M,  58,000 protein 
described previously (Froehner et al., 1987). 
Material purified from an extract using a column deriva- 
tized with anti-58,000 mAb 1351 was subjected to immuno- 
blotting analysis using mAb 1351, anti-dystrophin mAb  1808, 
and anti-87,000 mAb 20H2,  which  was one of the mabs used 
by Carr et al. (1989) to identify the M,  87,000 protein. The 
presumed 58,000 and 87,000 proteins and dystrophin were 
each specifically  recognized by the appropriate antibody (Fig. 
3, lanes 5-7). The two proteins recognized  by mAb 1351 and 
20H2, respectively, had identical mobilities to  the proteins 
recognized  by these mAbs in the  starting membranes (Fig. 3, 
lanes 2 and 3) .  MAb 1351 failed to recognize the M, 87,000 
protein in both  the membranes and  the immunoaffinity pu- 
rified preparations, confirming the evidence of Carr et al. 
(1989) that  the M,  58,000 and 87,000 proteins are unrelated 
proteins. 
These  data establish that  the M,  58,000 protein can occur 
in a complex with dystrophin. Not all the dystrophin in the 
extracts was in a complex with the M,  58,000 protein, however, 
since substantial  amounts of dystrophin remained in extracts 
which had been treated with an excess of mAb 1351 resin. 
Upon affinity purification using mAb 1808, this remaining 
dystrophin contained only very small amounts of both the M ,  
58,000 and 87,000 proteins relative to  the amount of dystro- 
phin (SDS-polyacrylamide gel electrophoresis data not 
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FIG. 3. Immunoblotting of Torpedo membranes and the pu- 
rified M, 58,000 protein complex. Torpedo postsynaptic mem- 
branes (lane I ) or M, 58,000 protein complex purified on  a mAb 1351 
IgG column (lane 4) were subjected to immunoblotting with anti- 
58,000  mAb 1351 (lanes 2 and 5), anti-87,000 mAb 20H2 (lanes 3 and 
6)  or anti-dystrophin mAb 1808 (lane 7). Lane 8 was incubated with 
control mouse IgG. Lanes 1 and 4 are Coomassie Blue stained; the 
lanes 2, 3, and 5-8 are immunoblots. Differences in mobility of the 
M, 58,000 and 87,000 proteins, when compared to  the gels in Fig. 1, 
are due to different SDS gel conditions. The relatively small  amount 
of dystrophin in the membranes could not be detected by anti- 
dystrophin mAb (data  not shown) because the conditions used for 
electrophoretic transfer (25 mM NaP04,  pH 6.5, for 2 h a t  250 mA) 
were inefficient for large proteins. 
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shown). Similarly, quantitative removal of dystrophin from 
extracts using mAb 1808 did not remove all the M ,  58,000 
protein.  When  the  remaining M ,  58,000 protein was captured 
using mAb 1351, it contained substantial amounts of M ,  
87,000 protein  (data  not  shown).  Hence,  the M ,  58,000 and 
87,000 proteins  can  apparently  exist in a complex independ- 
ently of dystrophin. The presence of small amounts of M ,  
87,000 protein in preparations of dystrophin (Fig. 1, lane 2 )  
would be compatible with  a  ternary M ,  58,000/87,000/dystro- 
phin complex. However, quantitative gel scanning showed 
that  the  ratio of M ,  87,000 to 58,000 protein was 2- to 3-fold 
lower in  dystrophin  preparations  than in M ,  58,000 prepara- 
tions  (starting with initial  extracts  in  both  cases). Much of 
the  dystrophin-bound M ,  58,000 protein is therefore  not  ac- 
companied by the M ,  87,000 protein,  and  the  origins of the 
small  amounts of M ,  87,000 protein in the  dystrophin  prepa- 
rations  are  not clear. 
If the M ,  58,000 protein  is associated with dystrophin  in 
skeletal muscle, as  has been suggested by indirect evidence 
(Kramarcy  and Sealock, 1990; Sealock et al., 1991), it could 
be  present in reduced quantities or even absent in dystrophin- 
minus muscle compared to  normal muscle. To test  this,  skel- 
etal and cardiac muscle from mdx mice and age-matched 
normal mice were probed for the M ,  58,000 protein by im- 
munofluorescence and  immunoblotting. As shown previously 
(Bonilla et  al., 1988; Chang et  al., 1989; Sealock et d., 1991), 
immunofluorescent  staining for dystrophin was confined to 
the sarcolemma of normal skeletal muscle (Fig. a), with 
particularly  strong  staining at  the  neuromuscular  junction, 
but was undetectable  in muscle from mdx mice (Fig. 4R).  The 
distribution of the M ,  58,000 protein in normal muscle is 
indistinguishable from that of dystrophin (Fig. 4C). In mdx 
muscle, however, the  intensity of anti-58,000 staining  on  the 
sarcolemma outside  the  neuromuscular  junction was on  av- 
erage markedly reduced (Fig. 4 0 ) ;  i t  ranged from almost 
FIG.  4. Distribution of M ,  58,000 protein  in  mouse  skeletal  
and  cardiac   muscle .  Immunofluorescence  oltliaphragm  muscle (A- 
I ) )  and cardiac muscle (FA', F) from normal mouse ( A ,  C, E )  or mdx 
mouse ( H ,  I ) ,  F). Cryostat  sections  were  incuhated  with  anti-dystro- 
phin  mAh 1808 ( A ,  H ) ,  or with  anti-58,000  protein  mAb 1351 CC, D) 
f'ollowed hy hiotinylated  anti-mouse IgG and fluorescein-avidin. For 
cardiac sections ( E ,  F), FITC-mAh 1351, followed hy rahhit anti- 
FITC  and  FITC-goat  anti-rabbit IgG was  used. Arrows in A, C, and 
1) indicate  neuromuscular  junctions. Bar in F, 12 pm. 
completely  negative in many mdx fibers to moderately strong 
but noticeably less intense than in normal fibers. Similar 
results were obtained in comparing  normal  and mdx cardiac 
muscle (Fig. 4, E and F) and  normal  and  Duchenne  human 
muscle (not  shown). 
A  consistent  and  notable exception to  this  pattern was the 
neuromuscular  junction in skeletal muscle. The  postsynaptic 
region of the  junction  (identified by staining with rhodamine- 
a-bungarotoxin) was consistently brightly stained by anti- 
58,000 mAb in both  normal  and mdx samples (Fig. 4, C and 
0). 
The decrease in anti-58,000  staining in mdx muscle was not 
a consequence of the general loss of cytoskeletal proteins 
associated with the  membrane, or of the physical state of the 
membrane. Staining of mdx muscle with antispectrin was 
only slightly reduced and somewhat more diffuse than in 
normal muscle (Fig. 5 ,  A and R ) .  Similar  results were ohtained 
with anti-a-actinin antibodies (not shown). In douhle label 
immunofluorescence for the M ,  58,000 protein  and vinculin 
in mdx muscle, antivinculin staining was essentially unaf- 
fected (Fig. 5, C and D),  even in regions that were almost 
completely  negative  for the M ,  58,000 protein (Fig. 5, F: and 
F ) .  These results indicate that the M ,  58,000 protein is 
selectively  lost in dystrophic muscle. 
On immunoblots of normal  and mdx mouse muscle, mAb 
1351 specifically recognized a single protein in both skeletal 
and  cardiac muscle  which  migrated  slightlv  more slowly than 
the Torpedo M ,  58,000 protein (Fig. 6). The  amounts of this 
muscle M ,  58,000 protein in normal uersus skeletal  (hind  leg) 
muscle (Fig. 6, upper panel) and in normal uprsus cardiac 
muscle (Fig. 6, lower panel) appeared in most experiments to 
be very similar or indistinguishable hv this method. In the 
experiment which showed the greatest divergence between 
normal  and mdx muscle  (shown in Fig. fi), the  amounts of M ,  
FIG. 5. Distribution o f  npecirin, -\fr T , H , 0 0 0  protein,  and 
v incul in   in  skelrtnl muscle .  I m m r ~ n o f l ~ ~ r ~ r e . ; c ~ e ~ ~ ~ ~ ~  of control ( A ,  (', 
E )  or mdx ( H ,  I ) .  1.') mnuse  gastrocncmir~s  mr~.;clc is shown.  Cryostat 
sections  were  incuhatetl  with  anti-spectrin mAh 4FH fnllowetl hy 
FITC-anti-mouse IgG ( A  and H ) .  The  two  hottom pnncls (('-PI arc 
doubled labeled with a mixture of rahhit anti-vinculin and ~ O I I S C  
anti-58,000 protein mAh 1351 follnwed hv rhodamine-laheled goat 
anti-rahhit IgG (shown in C'and 1 ) )  and fluorescein-lnt~eletl goat anti- 
mouse IgG (shown in E and PI. Nor i n  I) .  2 0  pm. 
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FIG. 6. Comparison of M. 58,000 protein in normal and 
mdx mouse skeletal  and  cardiac muscle. Upper panel: skeletal 
muscle; lower panel: cardiac muscle. Lanes I and 2 show  Coomassie 
Blue-stained gels of normal (N) or mdx ( M )  muscle (30 pg in each 
case) to demonstrate equal protein  loading of the samples. I ~ n m  3-7 
show  immunohlot  analysis  with  anti-58,000 mAh 1351. Lane 3 con- 
tains Torpedo AChR-rich  membranes (0.3 pg) showing the position 
of Torpedo M ,  58,000 protein. Lanes 4 and 5 contain 60 and 30 pg of 
normal  skeletal or cardiac muscle proteins, respectively. h n e s  6 and 
7 contain the same amounts of mdx skeletal or rndx cardiac  muscle, 
respectively. Incubation of companion immunohlots with control 
mouse IgG showed no staining. 
58,000 protein  in mdx  muscle appeared  to reduced a t  most by 
about 50%. These  data suggest that  the  abundance of the M ,  
58,000 protein does not depend to a large extent on the 
presence of dystrophin. 
DISCUSSION 
Using  monoclonal antibodies, we have  shown  that Torpedo 
dystrophin purified  by anti-dystrophin  immunoaffinity  chro- 
matography is accompanied by the M ,  58,000 protein.  Simi- 
larly,  dystrophin copurifies with  the M ,  58,000 protein isolated 
with  an  anti-58,000  antibody.  Since  neither  protein was cap- 
tured with control  antibodies or with  antibodies  against  other 
major  proteins in these  membranes ( M ,  43,000 protein  and 
AChR),  these  findings  constitute  strong evidence that  dystro- 
phin  and  the M ,  58,000 protein  exist  in a complex. The  two 
proteins  also occurred independently  in  our  Triton  extracts, 
since each  could  be captured  alone  after  complete  removal of 
the  other.  These individual entities  may reflect dissociation 
that occurs  after  membrane  solubilization, or may represent 
physiologically important  states of these  proteins. 
Our second finding was that immunoaffinity-purified M ,  
58,000 protein contained large quantities of the M ,  87,000 
postsynaptic  protein described by Carr et al. (1989). Th' IS was 
true  whether or not  dystrophin  was removed from extracts 
prior to capture of the M ,  58,000 protein. Hence, the M ,  
58,000 protein  also  apparently  forms  a  separate complex with 
the M ,  87,000 protein,  a possibility  which has  not been pre- 
viously suspected.  The M ,  87,000 protein was present in most 
of our  dystrophin  preparations (i.e. dystrophin  prepared  using 
antidystrophin  columns),  but  the  amounts were low. In  the 
absence of crossed immunoaffinity purification (the use of 
anti-87,000  columns  to  purify  dystrophin),  it is difficult to be 
certain  that  this  copurification was due  to  a specific associa- 
tion. The M ,  87,000 protein is unlikely to  mediate  the  inter- 
action between dystrophin and the M ,  58,000 protein since 
the M ,  87,000/58,000 protein  ratio was much lower in dystro- 
phin  preparations  than in M ,  58,000 protein  preparations. It 
remains possible that  the M, 58,000/87,000 complex could be 
associated  with  dystrophin in situ, but  that  during  memhrane 
preparation  and  solubilization,  the M, 87,000 protein largely 
dissociates from this  ternary complex.  At the  same  time,  the 
free M ,  58,000/87,000 complex would remain intact. The 
simpler  hypothesis is that of two binary complexes for the M ,  
58,000 protein,  but  further  studies  comparing  the composition 
of the complexes solubilized under different conditions are 
needed to definitively answer  these  questions. 
Other  proteins of M ,  140,000,45,000, and 30,000 also repro- 
ducibly  copurified  with dvstrophin  and  are  potential compo- 
nents of a dystrophin multiprotein complex. However, the 
amounts of these  proteins  relative to dvstrophin or the M, 
58,000 protein were low, and in the  absence of specific anti- 
bodies to  assess  the specificitv of their  appearance in these 
preparations, t,heir potential association w i t h  dystrophin is 
speculative. 
Several lines of indirect evidence, in addition to the well 
known similarities of Torppdo and mammalian muscle pro- 
teins, suggest that  a dystrophin", 58,000 complex also exists 
in muscle. In previous immunofluorescence experiments, we 
showed that,  to a high degree of precision, dvstrophin-positive 
regions of sarcolemma in cultured X m o p u s  muscle are also 
positive for the M ,  58,000 protein (Kramarcv and Sealock 
1990). Here we found  that  the  anti-58,000 mAh gave suhstan- 
tially reduced immunofluorescent  staining of dystrophin-mi- 
nus muscle relative  to  normal muscle,  with  some  fihers being 
nearly  negative for the M ,  58,000 protein.  The average steady 
state levels of the M ,  .58,000 protein in dystrophic (rndx)  
mouse  muscle, as assessed hy immunoblot. analvsis, were 
generally unaffected,  although  one  experiment showed a de- 
crease of approximately 505. We considered three possibili- 
ties to explain the decreased immunofluorescence staining. 
One is that lower abundance of the M ,  58,000 protein, al- 
though  minimal, is directly  responsihle for the reduced stain- 
ing of some fibers. A  second possibility is that  the  absence of 
dystrophin  hinders  the  incorporation of the M ,  58,000 protein 
onto the sarcolemma. Finally, an unlikely but formal alter- 
native possibility is that access of mAh 1351 to its epitope is 
hindered in the absence of dystrophin. In the absence of 
antibodies  against  additional  epitopes on the M ,  58,000 pro- 
tein, we cannot yet evaluate this possihilitv. Whatever the 
cause,  the  results  indicate  an  altered mode of association of 
the M ,  58,000 protein  with  the  membrane in the  absence of 
dystrophin. 
Our  findings  bear  strong  resemhlance  to some of the  results 
obtained with the purified dystrophin complex from rahbit 
skeletal muscle by Campbell and coworkers (Ervasti ~t al., 
1990). In  that complex, they found  two proteins of M ,  59,000 
and 88,000 and four glycoproteins of M, 156,000, 50,000, 
43,000, and 35,000. Ry the  criterion of molecular weight and 
staining intensities relative to dystrophin. the first two of 
these proteins are potent.ially the muscle homologs of the 
Torpedo M ,  58,000 and 87,000 proteins.  A  marked difference 
between  our  results  and  those of Ervasti ~t a/. (1990) is that 
we have so far failed to find evidence for glycoproteins in the 
Torpedo dystrophin complex. In several attempts, we failed 
to  isolate  dystrophin by affinity  procedures using  wheat germ 
agglutinin or concanavalin A, even though the presumptive 
Na,K-ATPase of electric  tissue  (an M ,  90.000 protein  present 
in  the  same  extracts) was  readily captured.', It will  be impor- 
' N. R. Kramarcy and R. Sealock, unpuhlished results. 
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tant  to determine whether these differences arise for technical 
reasons or because of species, tissue, or isoform differences. 
Our finding that  the M, 58,000 protein can occur in Triton 
extracts of postsynaptic  membranes  independently of dystro- 
phin may be  related to  the fact that  it is found  in  tissues  such 
as kidney that express dystrophin at  only very low  level^.^ 
Clusters of AChR in  cultured muscle are also rich in the M, 
58,000 protein  (Froehner et al., 1987) but, at  least in Xenopus 
muscle, contain little dystrophin (Sealock et al., 1991). In 
dystrophic muscle, immunofluorescent staining of the neuro- 
muscular junction with mAb 1351 remained bright while 
staining of the extrajunctional sarcolemma was  weak. The M, 
58,000 protein in mammalian tissues therefore appears to 
interact with additional  proteins, possibly including the M ,  
87,000 protein and  other members of the dystrophin family. 
Candidates in the latter include the muscle isoform of p- 
spectrin described by Bloch and Morrow (1989) and the 
dystrophin-related  protein described by Fardeau et al. (1990), 
both of which are  concentrated at  neuromuscular  junctions. 
Dystrophin-independent  activities for the M ,  58,000 protein 
may explain the partial reduction of M, 58,000 protein content 
and sarcolemmal incorporation in dystrophic muscle, in con- 
trast  to  the near total absence of the dystrophin-associated 
M, 156,000 glycoprotein studied by Ervasti et al. (1990). 
The function of the M, 58,000 protein is not known, and 
sequence analyses of Torpedo and mouse skeletal muscle 
cDNAs encoding the M ,  58,000 protein have not revealed 
homology to known  protein^.^ Its diminished association with 
the sarcolemma in  dystrophic muscle may, however, contrib- 
ute  to  the pathology of muscular dystrophy. Abnormalities in 
the function or expression of the M, 58,000 protein could also 
potentially be the primary defect in other muscle pathologies 
in which dystrophin is normal. 
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